ArTCell is a European research consortium from four partners (Belgium, Poland, the Netherlands and Italy). We aim to leap innovation by providing an artificial T cell for anti-tumour therapies, that can be produced from the bottom-up, in a safer, more efficient and cost-effective manner, using pharmaceutical-grade manufacturing facilities.
The ArTCell project has received funding from the Horizon Europe programme under grant agreement N° 101130715.
Company Details
- Employees
- 4
- Founded
- 2024
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.artcell.eu/
- Keywords
- SynEry.
Artcell Questions
Artcell's website is https://www.artcell.eu/
Artcell's LinkedIn profile is https://www.linkedin.com/company/artcell-eu
Artcell has
4 employees.
View email and phone details for 4
employees at Artcell.
Artcell's industry is
Biotechnology Research
Artcell's top competitors are
Lagom Pharmatech,
Department Of Biosystems,
Limni@ku Leuven,
Breathe Lab Ku Leuven,
Biomimetics Ku Leuven,
Genlumina,
Lammertyn Lab,
Pcr-4-All,
Synery,
3bs - Biomimetics, Biocarriers And Bioimplants (Dtu).
Artcell's categories are Biotechnology Research
Artcell's founding year is 2024
